Peer Reviewed

editorialoffice@confseries.net   +44 7897-071619

Follow Us:

Journal of Pharma and Drug Innovation

Frequency : Annual (One issue per year)
Manuscript Guidelines Journals Membership
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time
Krishna Chandra Panda
Roland Institute of Pharmaceutical Sciences, Khodasingi, Berhampur, Pin-760010, Odisha, India
Publications
Review Article
Gut Dysbiosis: A Key Player in Metabolic health Management
Author(s): Krishna Chandra Panda, B.V.V Ravi Kumar, Jammula Sruti, Digambar Bisoi and Laxmidhar Sahoo
Gut Dysbiosis: A Key Player in Metabolic health Management HTML PDF PDF

Publication Standards

Structured Peer Review

Expert Reviewer Evaluation

Transparent Review Process

Time-Bound Editorial Workflow

Open Access Publication

Ethical Publishing Standards

Timely Online Publication

Flyer Image

Flyer Image

Journal Highlights

Cutting-Edge Therapeutic Innovations Advanced Computational Drug Design Translational Pharmaceutical Research Smart and Targeted Delivery Platforms Synthetic and Green Chemistry Approaches Global Health and Access to Medicines Personalized and Precision Medicine Biologics, Biosimilars, and Immunotherapy Pharmaceutical Policy, Ethics, and Education

Recommended Journals

Journal of Pharma and Drug Innovation Journal of Neuroscience and Clinical Neurology Journal of Targeted Oncology Research Journal of Cardiovascular Care and Research

About Confseries

Confseries is a platform for publishing high-quality research journals across various disciplines. We aim to provide a seamless experience for authors, reviewers, and readers.

Useful Links

Home Submit Manuscript Author Guidelines Terms and Conditions Contact

Contact Information

+44-7897071619

cosmetics@confseries.net

support@confseries.com

Quick Links

Submit

Archive

Contact

Editors

Aims

Guidelines

© Copyright All rights reserved by Confseries